Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.
Valeant Pharmaceuticals faced another takeover fight Wednesday after Endo International submitted a higher bid for drugmaker Salix Pharmaceuticals.
Shares of Acadia Pharmaceuticals shed nearly a quarter of their value in premarket trading Thursday, a day after the drug developer announced the sudden retirement of its long-time CEO and said it will delay the regulatory submission for its most advanced product.
The sharp decline in Ebola cases since the peak of the virus’ largest-ever outbreak could hamper efforts to treat the disease in the future.
A dose of tetanus vaccine let patients live longer when added to an experimental treatment for the most common and deadly kind of brain tumor, researchers report.
Endo International is trying to lure fellow drugmaker Salix Pharmaceuticals with an offer Endo says is worth 11 percent more than the $10 billion Salix has agreed to accept from serial acquirer Valeant Pharmaceuticals.
The VSNC series replaces two existing products for NAMUR valve applications. With multiple coil options, including Class I Division 1(FM) or intrinsic safety, the VSNC is an excellent fit for ordinary environments and hazardous locations alike.
Prosecutors from Connecticut, Indiana and Puerto Rico have joined New York's attorney general in an investigation of the herbal supplement industry, saying they're building on the long track record of state attorneys general upholding the rights of consumers.
The World Health Organization says it has created a panel of independent experts to assess its response to the biggest-ever Ebola outbreak in history.
Two Democratic senators and a possible Republican presidential candidate joined forces Tuesday to push a bill to remove federal prohibitions on medical marijuana in 23 states where it's already legal.
Actavis and Allergan, Inc. announced that, at shareholder meetings held yesterday, all proposals related to Actavis’ planned acquisition of Allergan were approved by both Actavis’ and Allergan’s shareholders.
McNeil Consumer Healthcare, of Fort Washington, Pennsylvania, acknowledged failing to take corrective action after discovering the adulterated bottles of Infants' and Children's Tylenol and Children's Motrin. The company agreed to pay $25 million to resolve the case.
Pernix Ireland Limited has signed a definitive agreement to acquire the Zohydro ER franchise from Zogenix, Inc. The acquisition includes three extended release hydrocodone products, including an abuse-deterrent pipeline and all related intellectual property.
Healthcare industry analysts expect promising new pain therapy medications to hit the market in the near future despite a decline in recent pharmaceutical patent applications.
Democratic members of Congress hope to make substantial changes to single-load laundry detergent packets amid rising concerns about accidental ingestion by children.